What Types of Cancers are Targeted by PERK Inhibitors?
PERK inhibitors have shown potential in treating a variety of cancers, including breast cancer, lung cancer, and pancreatic cancer. These cancers are often characterized by high levels of endoplasmic reticulum stress, making them suitable candidates for PERK inhibitor treatment.
